Evidence mapPaperPMID 41612468Full record

ArticleBreast cancer research : BCR2026

One size does not fit all: data-driven insights of patient-reported outcomes to tailor supportive care in breast cancer.

Eva Boomstra, Kelly M de Ligt, Renaud Tissier, Felix Clouth, Sabine Linn, Floortje Mols, Iris M C van der Ploeg, Lonneke V van de Poll-Franse

Abstract read
In one paragraph

Article in Breast cancer research : BCR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eva BoomstraDepartment of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, PO Box 90203, 1006 BE, Amsterdam, The Netherlands. e.boomstra@nki.nl.ORCID http://orcid.org/0009-0006-4937-1656
Kelly M de LigtDepartment of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, PO Box 90203, 1006 BE, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9218-617X
Renaud TissierBiostatistics Center, Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-6602-939X
Felix ClouthDepartment of Methodology and Statistics, Tilburg University, Tilburg, The Netherlands.ORCID http://orcid.org/0000-0002-8359-9228
Sabine LinnDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-5541-0347
Floortje MolsDepartment of Medical and Clinical Psychology, Center of Research on Psychological and Somatic Disorders, Tilburg University, Tilburg, The Netherlands.ORCID http://orcid.org/0000-0003-0818-2913
Iris M C van der PloegDepartment of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-2805-2104
Lonneke V van de Poll-FranseDepartment of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, PO Box 90203, 1006 BE, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0413-6872

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSupportive care resources are limited, requiring a strategic, tailored approach, especially with the growing population of breast cancer patients. We examined whether routinely collected patient-reported outcome measures (PROMs) can identify meaningful health-related quality of life (HRQoL) trajectories and help guide resource allocation of supportive care.

methodsAs part of routine care at the Netherlands Cancer Institute, 2181 early-stage breast cancer patients completed the EORTC QLQ-C30 and BR23 before treatment and six months later. Through Latent Class and Latent Transition Analyses, we identified HRQoL subgroups and transitions between subgroups over time. Multinomial regression examined sociodemographic and clinical correlates. Network analysis detected key domains and inter-domain connections within subgroups.

resultsThree HRQoL subgroups were identified at baseline: Excellent HRQoL (53%), Good HRQoL with Psychosocial concerns (33%), and Poor HRQoL with severe functional limitations (13%). Multiple comorbidities and history of depression were independently and strongly associated with membership to less favorable subgroups. Subgroup transitions were rare (1–5%). Network analysis showed subgroup-specific key domains: emotional functioning in the Psychosocial concerns-subgroup, and menopausal symptoms, social, and role functioning in the Poor HRQoL-subgroup; the latter subgroup showing the highest interconnectivity between HRQoL-domains.

conclusionBaseline HRQoL and sociodemographic factors, independent of treatment, is associated with HRQoL trajectories and can guide efficient re-allocation of resources to those patients with complex needs. Most patients maintain excellent HRQoL and may benefit from low-intensity or self-management support, whereas targeted, multidisciplinary interventions should be prioritized for those with complex needs. Different key domains and connectivity suggest different types of supportive care are needed for different subgroups.

Indexed as

Breast NeoplasmsPatient Reported Outcome MeasuresQuality of LifeAdultAgedFemaleHumansMiddle AgedNetherlandsBreast cancerHealth-related quality of lifeLatent class analysisLatent transition analysisNetwork analysisSupportive careValue-based health care

Identifiers

PMID41612468
PMCPMC12930614

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.